Simplified Method for Detecting Autoantibodies to p53 in Cancer Patients
Author Information
Author(s): Cressey Ratchada, Pimpa Saranya, Chewaskulyong Busyamas, Lertprasertsuke Nirush, Saeteng Somchareon, Tayapiwatana Chatchai, Kasinrerk Watchara
Primary Institution: Chiang Mai University
Hypothesis
Can a simplified method for immobilizing tumor-associated antigens improve the detection of autoantibodies in cancer patients?
Conclusion
The study developed a method to directly coat tumor-associated antigens onto microtiter plates, which can effectively identify p53-specific autoantibodies in cancer patients.
Supporting Evidence
- The immobilized p53 antigens could differentiate between positive and negative sera for p53 autoantibodies.
- Reactivity of sera from lung cancer patients correlated highly with purified p53 antigen.
- Directly immobilized (His)6-p53 proteins showed similar reactivity to commercial antibodies.
Takeaway
Researchers found a simpler way to test for cancer by looking for specific antibodies in the blood that react to a protein called p53.
Methodology
The study used a simplified ELISA method to immobilize p53 antigens directly from crude lysates onto microtiter plates without prior purification.
Potential Biases
Potential for background reactivity from human sera to avidin-coated plates.
Limitations
Only one tumor antigen was examined, and the method may not be suitable for all types of antigens due to potential background reactivity.
Participant Demographics
68 lung cancer patients (36 adenocarcinomas, 32 squamous cell carcinomas) and 22 healthy volunteers.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website